Drugs Made In America Acquisition Corp. Ordinary Shares
$10.75
-0.01 (-0.09%)
Price as of Aug 28, 2026 market close
Performance
- 1 Month
- +0.4%
- 3 Months
- +1.3%
- YTD
- +3.6%
- 1 Year
- +4.8%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Volatility 1-year annualized
- 2.1%
- Largest decline max drawdown, since Aug 2025
- -0.5%
- Risk-adjusted return Sharpe ratio, 1-year
- 2.24
Own DMAA?
See how DMAA contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.